CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. FIFTH AMENDMENT TO TRADEMARK...Trademark License and Supply Agreement • February 20th, 2024 • Travere Therapeutics, Inc. • Pharmaceutical preparations
This Fifth Amendment to Trademark License and Supply Agreement (“Fifth Amendment”), made effective September 30, 2020 (the “Fifth Amendment Effective Date”), amends the Trademark License and Supply Agreement dated May 28, 2014 by and between Mission Pharmacal Company (“Mission”) and Retrophin, Inc. (together with its affiliates, “Retrophin”) (such agreement as previously amended by the amendments listed in Exhibit A to this Fifth Amendment, the “Agreement”).
ContractTrademark License and Supply Agreement • May 5th, 2020
EX-10.20 2 ex1020-1231201710k.htm EXHIBIT 10.20 Exhibit 10.24 ***Text Omitted and Filed Separately With Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 240.24b-2 of the Securities Exchange Act of 1934, as amended AMENDMENT TWO TO THE THIRD AMENDMENT TO TRADEMARK LICENSE AND SUPPLY AGREEMENT This Amendment Two to the Third Amendment to Trademark License and Supply Agreement dated November 3, 2017 (this “Amendment” and the “Effective Date”) amends the Third Amendment dated March 17, 2016 (as amended effective September 12, 2016 by the First Amendment to the Third Amendment, the “Third Amendment”) to the Trademark License and Supply Agreement by and between Mission Pharmacal Company (“Mission”) and Retrophin, Inc. (together with its affiliates, “Retrophin”) dated May 28, 2014 (“Agreement Effective Date”) (as amended by the amendments dated July 28, 2014 and September 30, 2015 and by the Third Amendment, the “Agreement”). WHEREA
CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION. TRADEMARK LICENSE AND SUPPLY AGREEMENTTrademark License and Supply Agreement • October 11th, 2007 • United Fuel & Energy Corp • Retail-nonstore retailers • Nevada
This Trademark License and Supply Agreement (this “Agreement”) is made as of October 5, 2007, by and between United Fuel & Energy, a Nevada corporation (the “UFEN”), and Southern Counties Oil Co., a California limited partnership, d.b.a. SC Fuels (“SC Fuels”).
THIRD AMENDMENT TO TRADEMARK LICENSE AND SUPPLY AGREEMENTTrademark License and Supply Agreement • May 5th, 2016 • Retrophin, Inc. • Pharmaceutical preparations
This Third Amendment dated March 17, 2016 (the “Amendment”) to the Trademark License and Supply Agreement (“Agreement”) dated May 28, 2014 (“Effective Date”) as amended July 28, 2014 and September 30, 2015 by and between Mission Pharmacal Company (“Mission”) and Retrophin, Inc. (together with its affiliates, “Retrophin”).
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT,Trademark License and Supply Agreement • February 20th, 2024 • Travere Therapeutics, Inc. • Pharmaceutical preparations
This Amendment One dated September 12, 2016 (the “Effective Date”) to the Third Amendment dated March 17, 2016 (the “Amendment”) to the Trademark License and Supply Agreement (“Agreement”) dated May 28, 2014 (“Effective Date”) as amended July 28, 2014 and September 30, 2015 by and between Mission Pharmacal Company (“Mission”) and Retrophin, Inc. (together with its affiliates, “Retrophin”).
AMENDMENT ONE TO THE THIRD AMENDMENT TO TRADEMARK LICENSE AND SUPPLY AGREEMENTTrademark License and Supply Agreement • November 4th, 2016 • Retrophin, Inc. • Pharmaceutical preparations
This Amendment One dated September 12, 2016 (the “Effective Date”) to the Third Amendment dated March 17, 2016 (the “Amendment”) to the Trademark License and Supply Agreement (“Agreement”) dated May 28, 2014 (“Effective Date”) as amended July 28, 2014 and September 30, 2015 by and between Mission Pharmacal Company (“Mission”) and Retrophin, Inc. (together with its affiliates, “Retrophin”).
c) Licensee represents and agrees that the Licensed Trademarks shall be used only as permitted by paragraphs (a) and (b) of this Section, and that the Licensed Trademarks shall not be used on any products other than the Licensed Products or in any...Trademark License and Supply Agreement • March 20th, 1996 • Stephan Co • Perfumes, cosmetics & other toilet preparations • Florida
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.Trademark License and Supply Agreement • February 20th, 2024 • Travere Therapeutics, Inc. • Pharmaceutical preparations
This Third Amendment dated March 17, 2016 (the “Amendment”) to the Trademark License and Supply Agreement (“Agreement”) dated May 28, 2014 (“Effective Date”) as amended July 28, 2014 and September 30, 2015 by and between Mission Pharmacal Company (“Mission”) and Retrophin, Inc. (together with its affiliates, “Retrophin”).
SECOND AMENDMENT TO TRADEMARK LICENSE AND SUPPLY AGREEMENTTrademark License and Supply Agreement • May 5th, 2016 • Retrophin, Inc. • Pharmaceutical preparations
A Trademark License and Supply Agreement (the “Agreement”) was entered into by and between MISSION PHARMACAL COMPANY (“Mission”) and RETROPHIN, INC. ("Retrophin") on May 28, 2014.
FOURTH AMENDMENT TO TRADEMARK LICENSE AND SUPPLY AGREEMENTTrademark License and Supply Agreement • February 26th, 2019 • Retrophin, Inc. • Pharmaceutical preparations
This Fourth Amendment to Trademark License and Supply Agreement (“Fourth Amendment”), made effective November 28, 2018 (the “Fourth Amendment Effective Date”), amends the Trademark License and Supply Agreement dated May 28, 2014 by and between Mission Pharmacal Company (“Mission”) and Retrophin, Inc. (together with its affiliates, “Retrophin”) (such agreement as previously amended by the amendments listed in Exhibit A, the “Agreement”).
Indicates omitted material that is the subject of a confidential treatment request filed separately with the Commission. TRADEMARK LICENSE AND SUPPLY AGREEMENTTrademark License and Supply Agreement • January 31st, 2007 • Mannatech Inc • Medicinal chemicals & botanical products • Texas
THIS TRADEMARK LICENSE AND SUPPLY AGREEMENT (this “Supply Agreement”) is dated this 25th day of January 2007 (the “Effective Date”) and is between CARRINGTON LABORATORIES, INC. (“CARRINGTON”), a Texas corporation with its principal place of business located at 2001 Walnut Hill Lane, Irving Texas 75038, and MANNATECH, INCORPORATED (“MANNATECH”), a Texas corporation with its principal place of business located at 600 S. Royal Lane, Suite 200, Coppell, Texas 75019. Collectively, CARRINGTON AND MANNATECH are hereinafter referred to as “Parties.”
FIRST AMENDMENT TO TRADEMARK LICENSE AND SUPPLY AGREEMENTTrademark License and Supply Agreement • July 29th, 2014 • Retrophin, Inc. • Pharmaceutical preparations
A Trademark License and Supply Agreement (the “Agreement”) was entered into by and between MISSION PHARMACAL COMPANY (“Mission”) and RETROPHIN, INC. ("Retrophin") on May 28, 2014.
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***],Trademark License and Supply Agreement • February 20th, 2024 • Travere Therapeutics, Inc. • Pharmaceutical preparations
This Amendment Two to the Third Amendment to Trademark License and Supply Agreement dated November 3, 2017 (this “Amendment” and the “Effective Date”) amends the Third Amendment dated March 17, 2016 (as amended effective September 12, 2016 by the First Amendment to the Third Amendment, the “Third Amendment”) to the Trademark License and Supply Agreement by and between Mission Pharmacal Company (“Mission”) and Retrophin, Inc. (together with its affiliates, “Retrophin”) dated May 28, 2014 (“Agreement Effective Date”) (as amended by the amendments dated July 28, 2014 and September 30, 2015 and by the Third Amendment, the “Agreement”).
Agreement --------- 1. Term. ---- The term of this Supply Agreement shall be for a period of thirty six (36) months from December 31, 2006 to December 31, 2009 (the "Term") unless further extended or sooner terminated as provided herein. The Term may...Trademark License and Supply Agreement • January 31st, 2007 • Carrington Laboratories Inc /Tx/ • Pharmaceutical preparations • Texas
